CardieX Limited (CDX.AX)
AUD 0.06
(-3.33%)
AUD 0.06
(-3.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 12.64 Million AUD | -11.55% |
| 2023 | 14.3 Million AUD | 15.55% |
| 2022 | 12.37 Million AUD | 9.89% |
| 2021 | 11.26 Million AUD | 5.52% |
| 2020 | 10.67 Million AUD | -19.2% |
| 2019 | 13.21 Million AUD | 105.99% |
| 2018 | 6.41 Million AUD | 116.68% |
| 2017 | 2.96 Million AUD | -35.7% |
| 2016 | 4.6 Million AUD | -22.68% |
| 2015 | 5.95 Million AUD | 28.55% |
| 2014 | 4.63 Million AUD | -27.35% |
| 2013 | 6.37 Million AUD | 52.45% |
| 2012 | 4.18 Million AUD | -20.37% |
| 2011 | 5.25 Million AUD | -11.01% |
| 2010 | 5.9 Million AUD | -25.3% |
| 2009 | 7.9 Million AUD | -0.64% |
| 2008 | 7.95 Million AUD | -30.28% |
| 2007 | 11.4 Million AUD | -28.03% |
| 2006 | 15.84 Million AUD | -22.08% |
| 2005 | 20.33 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 12.64 Million AUD | 0.0% |
| 2024 Q1 | 16.86 Million AUD | 17.93% |
| 2024 Q3 | 12.64 Million AUD | -25.0% |
| 2024 FY | 11.51 Million AUD | -19.45% |
| 2024 Q2 | 16.86 Million AUD | 0.0% |
| 2023 FY | 14.3 Million AUD | 15.55% |
| 2023 Q4 | 14.3 Million AUD | -1.61% |
| 2023 Q2 | 14.18 Million AUD | 0.0% |
| 2023 Q1 | 14.18 Million AUD | 18.13% |
| 2023 Q3 | 14.53 Million AUD | 2.46% |
| 2022 FY | 12.37 Million AUD | 9.89% |
| 2022 Q2 | 15.11 Million AUD | 0.0% |
| 2022 Q3 | 12.37 Million AUD | -18.1% |
| 2022 Q4 | 12.01 Million AUD | -2.97% |
| 2022 Q1 | 15.11 Million AUD | 34.18% |
| 2021 Q2 | 10.83 Million AUD | 0.0% |
| 2021 FY | 11.26 Million AUD | 5.52% |
| 2021 Q4 | 11.26 Million AUD | -6.61% |
| 2021 Q3 | 12.06 Million AUD | 11.36% |
| 2021 Q1 | 10.83 Million AUD | 1.46% |
| 2020 Q4 | 10.67 Million AUD | 0.0% |
| 2020 Q2 | 9.62 Million AUD | 0.0% |
| 2020 Q3 | 10.67 Million AUD | 10.94% |
| 2020 FY | 10.67 Million AUD | -19.2% |
| 2020 Q1 | 9.62 Million AUD | -27.17% |
| 2019 Q2 | 7.44 Million AUD | 0.0% |
| 2019 FY | 13.21 Million AUD | 105.99% |
| 2019 Q3 | 13.21 Million AUD | 77.36% |
| 2019 Q4 | 13.21 Million AUD | 0.0% |
| 2019 Q1 | 7.44 Million AUD | 16.14% |
| 2018 FY | 6.41 Million AUD | 116.68% |
| 2018 Q1 | 2.77 Million AUD | -6.41% |
| 2018 Q2 | 2.77 Million AUD | 0.0% |
| 2018 Q3 | 6.41 Million AUD | 131.52% |
| 2018 Q4 | 6.41 Million AUD | 0.0% |
| 2017 Q3 | 2.96 Million AUD | -30.72% |
| 2017 Q4 | 2.96 Million AUD | 0.0% |
| 2017 Q2 | 4.27 Million AUD | 0.0% |
| 2017 Q1 | 4.27 Million AUD | -7.19% |
| 2017 FY | 2.96 Million AUD | -35.7% |
| 2016 Q1 | 6.28 Million AUD | 5.61% |
| 2016 Q2 | 6.28 Million AUD | 0.0% |
| 2016 Q3 | 4.6 Million AUD | -26.79% |
| 2016 FY | 4.6 Million AUD | -22.68% |
| 2016 Q4 | 4.6 Million AUD | 0.0% |
| 2015 FY | 5.95 Million AUD | 28.55% |
| 2015 Q4 | 5.95 Million AUD | 0.0% |
| 2015 Q3 | 5.95 Million AUD | 10.53% |
| 2015 Q2 | 5.38 Million AUD | 0.0% |
| 2015 Q1 | 5.38 Million AUD | 16.31% |
| 2014 Q3 | 4.63 Million AUD | -22.96% |
| 2014 Q4 | 4.63 Million AUD | 0.0% |
| 2014 FY | 4.63 Million AUD | -27.35% |
| 2014 Q1 | 6.01 Million AUD | -5.7% |
| 2014 Q2 | 6.01 Million AUD | 0.0% |
| 2013 Q3 | 6.37 Million AUD | -7.69% |
| 2013 Q4 | 6.37 Million AUD | 0.0% |
| 2013 Q2 | 6.9 Million AUD | 0.0% |
| 2013 FY | 6.37 Million AUD | 52.45% |
| 2013 Q1 | 6.9 Million AUD | 65.14% |
| 2012 FY | 4.18 Million AUD | -20.37% |
| 2012 Q4 | 4.18 Million AUD | 0.0% |
| 2011 Q4 | 5.25 Million AUD | 0.0% |
| 2011 FY | 5.25 Million AUD | -11.01% |
| 2010 Q4 | 5.9 Million AUD | 0.0% |
| 2010 FY | 5.9 Million AUD | -25.3% |
| 2009 FY | 7.9 Million AUD | -0.64% |
| 2009 Q4 | 7.9 Million AUD | 0.0% |
| 2008 Q4 | 7.95 Million AUD | 0.0% |
| 2008 FY | 7.95 Million AUD | -30.28% |
| 2007 Q4 | 11.4 Million AUD | 0.0% |
| 2007 FY | 11.4 Million AUD | -28.03% |
| 2006 FY | 15.84 Million AUD | -22.08% |
| 2006 Q4 | 15.84 Million AUD | 0.0% |
| 2005 FY | 20.33 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 89.46% |
| Adherium Limited | 9.88 Million AUD | -27.942% |
| Aroa Biosurgery Limited | 101.82 Million AUD | 87.577% |
| Atomo Diagnostics Limited | 11.37 Million AUD | -11.168% |
| Anteris Technologies Ltd | 45.7 Million AUD | 72.321% |
| Control Bionics Limited | 9.02 Million AUD | -40.128% |
| Compumedics Limited | 40.35 Million AUD | 68.656% |
| Cochlear Limited | 2.74 Billion AUD | 99.539% |
| CleanSpace Holdings Limited | 26.05 Million AUD | 51.444% |
| Cyclopharm Limited | 45.91 Million AUD | 72.449% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | 47.23% |
| Nova Eye Medical Limited | 29.88 Million AUD | 57.668% |
| HeraMED Limited | 2.95 Million AUD | -328.503% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | -3.891% |
| ImpediMed Limited | 46.98 Million AUD | 73.078% |
| InhaleRx Limited | 1.57 Million AUD | -702.202% |
| LBT Innovations Limited | 7.93 Million AUD | -59.498% |
| Micro-X Limited | 26.89 Million AUD | 52.966% |
| Neurotech International Limited | 12.21 Million AUD | -3.573% |
| OncoSil Medical Limited | 6.71 Million AUD | -88.286% |
| PolyNovo Limited | 109.16 Million AUD | 88.412% |
| Respiri Limited | 6.19 Million AUD | -104.328% |
| SomnoMed Limited | 69.8 Million AUD | 81.878% |
| Universal Biosensors, Inc. | 30.12 Million AUD | 58.003% |
| Uscom Limited | 5.13 Million AUD | -146.363% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | -12.89% |